Detalhe da pesquisa
1.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer
; 129(23): 3772-3782, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769113
2.
Larotrectinib versus historical standard of care in patients with infantile fibrosarcoma: protocol of EPI-VITRAKVI.
Future Oncol
; 19(24): 1645-1653, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133249
3.
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Dig Liver Dis
; 55(8): 1019-1025, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217373
4.
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
Eur Respir J
; 39(6): 1354-60, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22034649
5.
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Eur Respir J
; 40(1): 17-27, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22135277
6.
A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.
Cytokine
; 60(3): 861-9, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22998942
7.
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
J Antimicrob Chemother
; 66(11): 2632-42, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21896561
8.
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Clin Infect Dis
; 46(10): 1499-509, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18419482
9.
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Int J Chron Obstruct Pulmon Dis
; 10: 985-93, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26082623
10.
Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
Clin Pharmacol Ther
; 74(4): 353-63, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14534522
11.
Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.
Surg Infect (Larchmt)
; 15(5): 567-75, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24833256
12.
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.
PLoS One
; 8(4): e61927, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23626752
13.
Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.
Adv Ther
; 30(6): 630-43, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797470
14.
Moxifloxacin safety: an analysis of 14 years of clinical data.
Drugs R D
; 12(2): 71-100, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715866
15.
Update on the cardiac safety of moxifloxacin.
Curr Drug Saf
; 7(2): 149-63, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22873499
16.
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
Int J Chron Obstruct Pulmon Dis
; 6: 373-83, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21760724
17.
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.
Antimicrob Agents Chemother
; 47(5): 1621-9, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12709331
18.
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Eur Arch Otorhinolaryngol
; 260(4): 186-94, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12709801